• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015年拟议的医疗保险药物治疗管理服务资格标准的差异影响

Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

作者信息

Wang Junling, Qiao Yanru, Spivey Christina A, Li Christine, Clark Caroline, Deng Yuewen, Liu Flora, Tillman Jeffrey, Chisholm-Burns Marie

机构信息

Department of Clinical Pharmacy, The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Room 221, Memphis, TN 38163.

Department of Clinical Pharmacy, The University of Tennessee Health Science Center College of Pharmacy, 881 Madison Avenue, Room 212, Memphis, TN 38163, , ,

出版信息

J Pharm Health Serv Res. 2016 Dec;7(4):209-215. doi: 10.1111/jphs.12142. Epub 2016 May 26.

DOI:10.1111/jphs.12142
PMID:28025599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5181845/
Abstract

OBJECTIVES

Previous studies found that racial and ethnic minorities may be less likely than non-Hispanic Whites (Whites) to meet existing Medicare medication therapy management (MTM) eligibility criteria. To address these issues, the Centers for Medicare & Medicaid Services (CMS) proposed alternative Medicare MTM eligibility criteria for 2015. Due to opposition to other Part D reforms proposed simultaneously by various stakeholders, CMS rescinded all proposed reforms. This study was conducted to determine whether non-Hispanic Blacks (Blacks) and Hispanics have lower likelihood of meeting the proposed 2015 Medicare MTM eligibility criteria.

METHODS

This retrospective observational analysis used Medical Expenditure Panel Survey data (2010-2011). The final study sample was comprised of 2,721 Whites (weighted to 37,185,896), 917 Blacks (weighted to 4,665,644), and 538 Hispanics (weighted to 3,532,882). Chi-square tests were used to examine racial and ethnic disparities in meeting proposed 2015 MTM eligibility criteria and each component of proposed 2015 MTM eligibility criteria. In multivariate analysis, a logistic regression model was used to control for population socio-demographic and health-related characteristics.

KEY FINDINGS

Compared to Whites with a proportion of MTM eligibility of 58.82%, the eligible proportion was 57.09% (=0.20) for Blacks, and 48.97% (<0.0001) for Hispanics, respectively. According to multivariate logistic regression, odds ratios of meeting MTM eligibility for Blacks and Hispanics compared to Whites were 0.74 (95% Confidence Internal [CI] = 0.62-0.88) and 0.53 (95% CI=0.43-0.67), respectively.

CONCLUSIONS

The proposed 2015 MTM eligibility criteria would not eliminate racial and ethnic disparities in MTM eligibility. Alternative MTM eligibility criteria should be devised.

摘要

目标

以往研究发现,少数族裔可能比非西班牙裔白人(白人)更不容易满足现行医疗保险药物治疗管理(MTM)的资格标准。为解决这些问题,医疗保险和医疗补助服务中心(CMS)提出了2015年医疗保险MTM资格标准的替代方案。由于各利益相关方同时对其他D部分改革提出反对意见,CMS撤销了所有提议的改革。本研究旨在确定非西班牙裔黑人(黑人)和西班牙裔满足2015年提议的医疗保险MTM资格标准的可能性是否较低。

方法

这项回顾性观察分析使用了医疗支出小组调查数据(2010 - 2011年)。最终研究样本包括2721名白人(加权至37185896人)、917名黑人(加权至4665644人)和538名西班牙裔(加权至3532882人)。卡方检验用于检验在满足2015年提议的MTM资格标准及2015年提议的MTM资格标准的每个组成部分方面的种族和族裔差异。在多变量分析中,使用逻辑回归模型来控制人群的社会人口统计学和健康相关特征。

主要发现

与MTM资格比例为58.82%的白人相比,黑人的合格比例为57.09%(P = 0.20),西班牙裔为48.97%(P < 0.0001)。根据多变量逻辑回归,与白人相比,黑人和西班牙裔满足MTM资格的优势比分别为0.74(95%置信区间[CI] = 0.62 - 0.88)和0.53(95% CI = 0.43 - 0.67)。

结论

提议的2015年MTM资格标准无法消除MTM资格方面的种族和族裔差异。应制定替代的MTM资格标准。

相似文献

1
Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.2015年拟议的医疗保险药物治疗管理服务资格标准的差异影响
J Pharm Health Serv Res. 2016 Dec;7(4):209-215. doi: 10.1111/jphs.12142. Epub 2016 May 26.
2
Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.《平价医疗法案》中药物治疗管理资格标准对不同种族和族裔群体的潜在健康影响。
J Manag Care Spec Pharm. 2015 Nov;21(11):993-1003. doi: 10.18553/jmcp.2015.21.11.993.
3
Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.基于星级评定与《医疗保险现代化法案》相比,在符合 MTM 资格标准方面的种族和民族差异。
J Manag Care Spec Pharm. 2018 Feb;24(2):97-107. doi: 10.18553/jmcp.2018.24.2.97.
4
Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.哮喘患者在符合药物治疗管理(MTM)资格标准方面的种族和族裔差异。
J Asthma. 2017 Jun;54(5):504-513. doi: 10.1080/02770903.2016.1238927. Epub 2016 Sep 27.
5
Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.种族和民族差异在符合 MTM 资格标准方面对健康的潜在影响。
Res Social Adm Pharm. 2014 Jan-Feb;10(1):106-25. doi: 10.1016/j.sapharm.2013.03.007. Epub 2013 Jun 10.
6
Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.非老年人口在满足 Part D MTM 资格标准方面的种族和民族差异。
J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e87-96. doi: 10.1331/JAPhA.2012.11146.
7
Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.非医疗保险人群在满足医疗保险药物治疗管理资格方面的种族和族裔差异的历史趋势。
Res Social Adm Pharm. 2014 Nov-Dec;10(6):904-917. doi: 10.1016/j.sapharm.2014.02.007. Epub 2014 Mar 2.
8
Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.医疗保险D部分对药物治疗管理资格标准的差异影响
Am Health Drug Benefits. 2014 Sep;7(6):346-58.
9
Historical trend of disparity implications of Medicare MTM eligibility criteria.医疗保险药物治疗管理资格标准差异含义的历史趋势。
Res Social Adm Pharm. 2013 Nov-Dec;9(6):758-69. doi: 10.1016/j.sapharm.2012.09.003. Epub 2012 Oct 10.
10
Disparity implications of Medicare eligibility criteria for medication therapy management services.医疗保险资格标准对药物治疗管理服务的差异影响。
Health Serv Res. 2010 Aug;45(4):1061-82. doi: 10.1111/j.1475-6773.2010.01118.x. Epub 2010 May 24.

引用本文的文献

1
Impact of medication therapy management programs on potentially inappropriate medication use in older adults: A systematic review.药物治疗管理方案对老年人潜在不适当用药的影响:系统评价。
J Manag Care Spec Pharm. 2024 Jan;30(1):3-14. doi: 10.18553/jmcp.2024.30.1.03.
2
Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.医疗保险药物治疗管理项目注册中的种族和族裔差异。
J Pharm Health Serv Res. 2023 Mar 30;14(2):188-197. doi: 10.1093/jphsr/rmad010. eCollection 2023 Jun.
3
Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.在 Medicare 受益人群中,患有阿尔茨海默病和相关痴呆症的患者中,药物治疗管理项目的入组存在种族/民族差异。
Curr Med Res Opin. 2022 Oct;38(10):1715-1725. doi: 10.1080/03007995.2022.2103962. Epub 2022 Aug 9.
4
Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.医疗保险D部分综合药物审查对药物依从性方面种族和民族差异的影响。
Am Health Drug Benefits. 2021 Sep;14(3):101-109.
5
Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.医疗保险全面药物审查对阿尔茨海默病患者他汀类药物不依从种族/民族差异的影响:一项观察性分析。
BMC Health Serv Res. 2022 Feb 7;22(1):159. doi: 10.1186/s12913-022-07483-8.
6
Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.老年医疗保险D部分受益人的药物治疗管理接受模式及预测因素
Res Social Adm Pharm. 2020 Sep;16(9):1208-1214. doi: 10.1016/j.sapharm.2019.12.007. Epub 2019 Dec 9.
7
Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues.在《医疗保险修正法案》(MMA)和《平价医疗法案》(ACA)下,MTM资格标准在识别有药物使用问题个体方面的阳性预测值。
J Pharm Health Serv Res. 2018 Dec;9(4):393-401. doi: 10.1111/jphs.12266. Epub 2018 Sep 7.
8
Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.药物治疗管理资格标准在不同种族/族裔群体中的比较效果。
J Am Geriatr Soc. 2019 Mar;67(3):581-587. doi: 10.1111/jgs.15754. Epub 2019 Jan 23.
9
Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.甲基丙二酸血症(MMA)预测价值阳性高于乙酰辅酶A羧化酶(ACA)医保资格标准对少数族裔的影响:一项观察性研究
Inquiry. 2018 Jan-Dec;55:46958018795749. doi: 10.1177/0046958018795749.
10
Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.基于星级评定与《医疗保险现代化法案》相比,在符合 MTM 资格标准方面的种族和民族差异。
J Manag Care Spec Pharm. 2018 Feb;24(2):97-107. doi: 10.18553/jmcp.2018.24.2.97.

本文引用的文献

1
Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.医疗保险D部分对药物治疗管理资格标准的差异影响
Am Health Drug Benefits. 2014 Sep;7(6):346-58.
2
Medicare backs off on MTM changes: congressional and patient-group opposition to other, more controversial part d reforms sank the plan.医疗保险放弃药物治疗管理变革:国会及患者团体对其他更具争议性的D部分改革的反对使该计划流产。
P T. 2014 Jul;39(7):463-519.
3
Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.种族和民族差异在满足医疗保险药物治疗管理资格标准方面的潜在影响。
J Pharm Health Serv Res. 2014 Jun;5(2):109-118. doi: 10.1111/jphs.12055.
4
Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule.医疗保险计划;2015 年医保优势计划和医疗保险处方药福利计划的合同年度政策与技术变更。最终规则。
Fed Regist. 2014 May 23;79(100):29843-968.
5
Impact of a Medicare MTM program: evaluating clinical and economic outcomes.医疗保险药物治疗管理(MTM)项目的影响:评估临床和经济结果。
Am J Manag Care. 2014 Feb 1;20(2):e43-51.
6
Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.种族和民族差异在符合 MTM 资格标准方面对健康的潜在影响。
Res Social Adm Pharm. 2014 Jan-Feb;10(1):106-25. doi: 10.1016/j.sapharm.2013.03.007. Epub 2013 Jun 10.
7
Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review.医疗保险药物治疗管理资格标准的差异影响:文献综述。
Expert Rev Pharmacoecon Outcomes Res. 2013 Apr;13(2):201-16. doi: 10.1586/erp.13.6.
8
Historical trend of disparity implications of Medicare MTM eligibility criteria.医疗保险药物治疗管理资格标准差异含义的历史趋势。
Res Social Adm Pharm. 2013 Nov-Dec;9(6):758-69. doi: 10.1016/j.sapharm.2012.09.003. Epub 2012 Oct 10.
9
Estimating the economic burden of racial health inequalities in the United States.估算美国种族健康不平等造成的经济负担。
Int J Health Serv. 2011;41(2):231-8. doi: 10.2190/HS.41.2.c.
10
Toward a fourth generation of disparities research to achieve health equity.迈向实现健康公平的第四代差异研究。
Annu Rev Public Health. 2011;32:399-416. doi: 10.1146/annurev-publhealth-031210-101136.